Literature DB >> 8035398

Colchicine disposition in patients with familial Mediterranean fever with renal impairment.

E Ben-Chetrit1, J M Scherrmann, E Zylber-Katz, M Levy.   

Abstract

OBJECTIVE: To assess the pharmacokinetics of serum colchicine in patients with familial Mediterranean fever (FMF) with renal impairment.
METHODS: Using a specific radioimmunoassay we determined serum colchicine concentration at various time points following oral administration of a single dose of the drug.
RESULTS: Patients with renal insufficiency had a mean +/- SD apparent total colchicine clearance of 0.168 +/- 0.063 l/h/kg, apparent volume of distribution of 4.56 +/- 1.64 l/kg and elimination half-life (t1/2) of 18.8 +/- 1.2 h. Patients with FMF with normal kidney function had a mean clearance of 0.726 +/- 0.110 l/h/kg, volume of distribution of 4.87 +/- 2.05 l/kg and terminal t1/2 of 4.4 +/- 1.0 h.
CONCLUSION: The kidneys have an important role in the clearance of colchicine. Caution should be exercised in the use of colchicine in patients with renal insufficiency.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8035398

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  8 in total

Review 1.  Gout in solid organ transplantation: a challenging clinical problem.

Authors:  Lisa Stamp; Martin Searle; John O'Donnell; Peter Chapman
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 2.  Colchicine: old and new.

Authors:  Anastasia Slobodnick; Binita Shah; Michael H Pillinger; Svetlana Krasnokutsky
Journal:  Am J Med       Date:  2014-12-30       Impact factor: 4.965

Review 3.  Update on colchicine and its mechanism of action.

Authors:  Yair Molad
Journal:  Curr Rheumatol Rep       Date:  2002-06       Impact factor: 4.592

Review 4.  Consensus Statement Regarding the Efficacy and Safety of Long-Term Low-Dose Colchicine in Gout and Cardiovascular Disease.

Authors:  Philip C Robinson; Robert Terkeltaub; Michael H Pillinger; Binita Shah; Vangelis Karalis; Eleni Karatza; David Liew; Massimo Imazio; Jan H Cornel; Peter L Thompson; Mark Nidorf
Journal:  Am J Med       Date:  2021-08-18       Impact factor: 4.965

Review 5.  Colchicine: its mechanism of action and efficacy in crystal-induced inflammation.

Authors:  George Nuki
Journal:  Curr Rheumatol Rep       Date:  2008-07       Impact factor: 4.592

6.  Colchicine suppresses neutrophil superoxide production in a murine model of gouty arthritis: a rationale for use of low-dose colchicine.

Authors:  E W Chia; R Grainger; J L Harper
Journal:  Br J Pharmacol       Date:  2008-02-11       Impact factor: 8.739

7.  Binding and drug displacement study of colchicine and bovine serum albumin in presence of azithromycin using multispectroscopic techniques and molecular dynamic simulation.

Authors:  Tanveer A Wani; Ahmed H Bakheit; Abdulrahman A Al-Majed; Nojood Altwaijry; Anwar Baquaysh; Ashwaq Aljuraisy; Seema Zargar
Journal:  J Mol Liq       Date:  2021-03-18       Impact factor: 6.165

Review 8.  Pharmacological Therapies for the Management of Inflammatory Bone Resorption in Periodontal Disease: A Review of Preclinical Studies.

Authors:  Angelica Leticia Reis Pavanelli; Bruna Silva de Menezes; Erica Bianca Barbosa Pereira; Fabio Assuncao de Souza Morais; Joni Augusto Cirelli; Rafael Scaf de Molon
Journal:  Biomed Res Int       Date:  2022-05-02       Impact factor: 3.246

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.